Dialog Box

Rare Cancers Australia

Counting the cost: how we can assess the true value of investing in cancer treatment

A cancer diagnosis has profound and enduring effects on individuals and extends its impact to loved ones, colleagues, communities, and across society.

People affected by cancer have told us what matters most to them - celebrating family milestones, actively participating in society, reducing the mental health burden on families, or being able to go back to school or work.

In collaboration with Canteen, we've published two reports exploring what we should value when investing in cancer treatments. The first report, Counting the cost: The true value of investing in cancer treatment, introduced the concept of social return on investment analysis as a way to measure the value of social and personal benefits.

Our follow-up report, Counting the cost: How we can assess the true value of investing in cancer treatment, takes this a step further. It provides a practical case study demonstrating how we can effectively integrate social value into health technology assessments.

Download the report 

An initiative of RCA and Canteen 

Share your experiences

Your experiences can help shape change. A review into health technology assessment (the HTA Review) is in progress and people affected by cancer or other health conditions are invited to make submissions. You can share your personal story to help drive reform in our HTA system to better consider all factors that contribute to the value of a treatment.

Make a submission 

Watch the webinar